| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.3 | 2e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |